Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:126:257-79.
doi: 10.1016/bs.acr.2014.11.005. Epub 2015 Feb 7.

Glycosylation and liver cancer

Affiliations
Review

Glycosylation and liver cancer

Anand Mehta et al. Adv Cancer Res. 2015.

Abstract

Liver cancer is the fifth most common cancer, but the second leading cause of cancer death, in the world, with more than 700,000 fatalities annually. The major etiology of liver cancer is infection with an hepatotropic virus such as hepatitis B virus or hepatitis C virus infection. While chronic viral infection remains the main cause of liver disease and risk of hepatocellular carcinoma (HCC), rates of nonviral-associated HCC are occurring at an alarmingly increasing rate. Like many cancers, survival rates are closely associated with time of detection. If HCC is caught early, survival rates can be as high as 50%. Regrettably, most cases of HCC are caught late where survival rates can be as low as 2-7%. Thus, there has been great interest in discovering serum biomarkers that could be used to identify those with HCC. To this end, many groups have examined the N-linked glycans to identify changes that occur with HCC. As the liver secretes the vast majority of proteins into the serum, this has often been a starting point for study. In serum, alterations in core fucosylation, outer-arm fucosylation, increased sialylation, and glycan branching have been observed in patients with HCC. Similar findings have been found directly in HCC tissue suggesting that these glycan changes may play a role in tumor formation and development.

Keywords: Fucosylation; Glycomics; Glycoproteomics; Glycosylation; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Liver cancer; Nash.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Rates of liver and intrahepatic bile duct cancer in the United States in from 1990 to 2014. Data is based upon the SEER Cancer Statistics Review (CSR) 1975–2011 and the NCI web-site on liver cancer (http://www.cancer.gov/cancertopics/types/liver).
Figure 2
Figure 2
Lectin staining of HCC or adjacent normal tissue with a recombinant Aleuria aurantia lectin (AAL) that has greater affinity for core fucosylated glycan. Panels A (4X) and B (20x) are from tissue adjacent to the HCC. Areas of staining indicated with the asterisks are the liver sinusoids, which stain with the core fucose binding lectin. Panels C (4X) and D (20x) are from the HCC tissue. In addition to the liver sinusoids, which stain with the core fucose binding lectin as in panels A and B, defined staining of hepatocytes, as indicted by the arrows, can also be seen.

References

    1. Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, Sayed D. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma. Ann Hepatol. 2011;10:296–305. - PubMed
    1. Ahn JM, Sung HJ, Yoon YH, Kim BG, Yang WS, Lee C, Park HM, Kim BJ, Lee SY, An HJ, Cho JY. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Molecular & cellular proteomics: MCP. 2014;13:30–48. - PMC - PubMed
    1. Ahn YH, Shin PM, Ji ES, Kim H, Yoo JS. A lectin-coupled, multiple reaction monitoring based quantitative analysis of human plasma glycoproteins by mass spectrometry. Anal Bioanal Chem. 2012a;402:2101–2112. - PubMed
    1. Ahn YH, Shin PM, Oh NR, Park GW, Kim H, Yoo JS. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma. J Proteomics 2012b - PubMed
    1. Ai J, Tan Y, Ying W, Hong Y, Liu S, Wu M, Qian X, Wang H. Proteome analysis of hepatocellular carcinoma by laser capture microdissection. Proteomics. 2006;6:538–546. - PubMed